ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Revenue 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$178.0MFY2024 · since FY2016: $14.2M → $178.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $178.0M | +195.3% |
| FY2023 | $60.3M | +122.0% |
| FY2022 | $27.1M | +341.5% |
| FY2021 | $6.1M | +55.4% |
| FY2020 | $4.0M | +252.8% |
| FY2019 | $1.1M | -98.1% |
| FY2018 | $59.5M | +57.3% |
| FY2017 | $37.8M | +166.5% |
| FY2016 | $14.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice